日本語 | English

Company history

September 1997 Established Pharma Foods Research Co., Ltd., a functional food ingredient development and sales company in Kyoto prefecture with a capital of 10 million Japanese yen
October 2000 Invested in Pharma Bio Co., Ltd., a Korean sales office to expand sales into the Korean market (50% PFI shares)
May 2001 Introduction of Ovopron, a Helicobacter Pylori antibody in the market
September 2001 Introduction of PharmaGABA, a GABA-containing ingredient in the market
October 2003 Introduction of Delicious Catechin, a catechin ingredient
July 2004 Acquired Pharma Bio Co., Ltd. by purchasing 100% shares
October 2004 Changed the company name to Pharma Foods International Co., Ltd.
March 2005 Introduction of PF-αlipoic acid, α-lipoic acid ingredient
May 2006 Established KEIHANNA Research center for Bio Medical development
May 2006 Introduction of Bonepep, an egg yolk peptide ingredient
June 2006 Went public and listed in Mothers, a Tokyo Stock Exchange market
September 2006 Moved the head office to the west ward of Kyoto (to the current location)
October 2006 Introduction of Runpep, an egg white peptide ingredient
April 2007 Renamed Pharma Bio Co., Ltd. in Korea to Pharma Foods Korea Co., Ltd.
April 2007 Established Hiroshima Bio Medical company in Hiroshima (49% PFI shares)
February 2010 Created LSI Department to launch CRO business
September 2010 Launched Enriched Folic Acid eggs business in China
February 2012 Started B to C business
July 2012 Established Dongbu Farm PFI. Co., Ltd. in partnership with Dongbu group in Korea (49% PFI shares)
July 2012 Introduction of iHA, hyaluronic acid production stimulating ingredient
August 2012 Launched ‘Tamagokichi’, a B to C direct sales brand and introduced a new joint health supplement ‘Tamagosamine with iHA’
October 2012 Acquired additional shares of Benart Co., Ltd. (50% PFI shares)
September 2013 Started sale of electricity produced by Benart Co., Ltd.
September 2013 Invested in and established CAF Co., Ltd., a pet food distribution company with Nihon Pet Food Co., Ltd. and Pulmuwon Health & Living Co., Ltd in Korea (30% PFI shares)
September 2013 Acquired Hiroshima Bio Medical company